Afficher la couverture 'Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis | Trabanelli, Sara' en grand format
/5

0 avis

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

Archive ouverte

Trabanelli, Sara | Chevalier, Mathieu | Martinez-Usatorre, Amaia | Gomez-Cadena, Alejandra | Salomé, Bérengère | Lecciso, Mariangela | Salvestrini, Valentina | Verdeil, Grégory | Racle, Julien | Papayannidis, Cristina | Morita, Hideaki | Pizzitola, Irene | Grandclément, Camille | Bohner, Perrine | Bruni, Elena | Girotra, Mukul | Pallavi, Rani | Falvo, Paolo | Leibundgut, Elisabeth Oppliger | Baerlocher, Gabriela | Carlo-Stella, Carmelo | Taurino, Daniela | Santoro, Armando | Spinelli, Orietta | Rambaldi, Alessandro | Giarin, Emanuela | Basso, Giuseppe | Tresoldi, Cristina | Ciceri, Fabio | Gfeller, David | Akdis, Cezmi | Mazzarella, Luca | Minucci, Saverio | Pelicci, Pier Giuseppe | Marcenaro, Emanuela | Mckenzie, Andrew | Vanhecke, Dominique | Coukos, George | Mavilio, Domenico | Curti, Antonio | Derré, Laurent | Jandus, Camilla

Edité par CCSD ; Nature Publishing Group -

International audience. Group 2 innate lymphoid cells (ILC2s) are involved in human diseases, such as allergy, atopic dermatitis and nasal polyposis, but their function in human cancer remains unclear. Here we show that, in acute promyelocytic leukaemia (APL), ILC2s are increased and hyper-activated through the interaction of CRTH2 and NKp30 with elevated tumour-derived PGD2 and B7H6, respectively. ILC2s, in turn, activate monocytic myeloid-derived suppressor cells (M-MDSCs) via IL-13 secretion. Upon treating APL with all-trans retinoic acid and achieving complete remission, the levels of PGD2, NKp30, ILC2s, IL-13 and M-MDSCs are restored. Similarly, disruption of this tumour immunosuppressive axis by specifically blocking PGD2, IL-13 and NKp30 partially restores ILC2 and M-MDSC levels and results in increased survival. Thus, using APL as a model, we uncover a tolerogenic pathway that may represent a relevant immunosuppressive, therapeutic targetable, mechanism operating in various human tumour types, as supported by our observations in prostate cancer.

Suggestions

Du même auteur

Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment

Archive ouverte | Gomez-Cadena, Alejandra | CCSD

International audience. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the current COVID-19 disease pandemic. In some patients, the symptoms are mild, and a fraction of SARS-CoV-2-in...

Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells

Archive ouverte | Mastelic-Gavillet, Beatris | CCSD

International audience. Background Several mechanisms are present in the tumor microenvironment (TME) to impair cytotoxic T cell responses potentially able to control tumor growth. Among these, the accumulation of a...

NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions

Archive ouverte | Cazzetta, Valentina | CCSD

International audience. Human Vδ2 cells are innate-like γδ T effectors performing potent immune surveillance against tumors. The constitutive expression of NKG2A identifies a subset of Vδ2 T cells licensed with an i...

Chargement des enrichissements...